AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen free cash flow 1988–2026

Amgen's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 3.65B USD, down 14.0% on the same quarter a year before. Amgen's free cash flow over the last twelve months was 9.58B USD, down 17.0% on the twelve months before. In fiscal year 2025 it was 8.10B USD, down 22.1% on the year before.

Last updated 12 Nov 2026 · Next report 2 Feb 2027

Free cash flow

Free cash flow · -0.4% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20269.58B-16.97%24.61%12.04B-2.45B17.60
FY202531 Dec 20258.10B-22.07%22.05%9.96B-1.86B14.94
FY202431 Dec 202410.39B+41.24%31.10%11.49B-1.10B19.21
FY202331 Dec 20237.36B-16.23%26.11%8.47B-1.11B13.68
FY202231 Dec 20228.79B+4.82%33.37%9.72B-936.00M16.24
FY202131 Dec 20218.38B-15.25%32.26%9.26B-880.00M14.63
FY202031 Dec 20209.89B+15.90%38.90%10.50B-608.00M16.76
FY201931 Dec 20198.53B-19.19%36.52%9.15B-618.00M14.01
FY201831 Dec 201810.56B+0.43%44.46%11.30B-738.00M15.88
FY201731 Dec 201710.51B+10.47%46.01%11.18B-664.00M14.30
FY201631 Dec 20169.52B+12.92%41.39%10.35B-837.00M12.62
FY201531 Dec 20158.43B+11.60%38.91%9.08B-649.00M11.00
FY201431 Dec 20147.55B+34.91%37.64%8.56B-1.00B9.81
FY201331 Dec 20135.60B+7.80%29.97%6.29B-693.00M7.32
FY201231 Dec 20125.19B+14.08%30.08%5.88B-689.00M6.60
FY201131 Dec 20114.55B-12.58%29.21%5.12B-567.00M4.99
FY201031 Dec 20105.21B-10.32%34.59%5.79B-580.00M5.40
FY200931 Dec 20095.81B+9.22%39.65%6.34B-530.00M5.69
FY200831 Dec 20085.32B+28.59%35.43%5.99B-672.00M4.95
FY200731 Dec 20074.13B-0.89%27.99%5.40B-1.27B3.68
FY200631 Dec 20064.17B+3.14%29.23%5.39B-1.22B3.51
FY200531 Dec 20054.04B+71.28%32.53%4.91B-867.00M3.21
FY200431 Dec 20042.36B+6.84%22.38%3.70B-1.34B1.79
FY200331 Dec 20032.21B+38.95%26.45%3.57B-1.36B1.64
FY200231 Dec 20021.59B+53.15%28.79%2.25B-658.50M1.38
FY200131 Dec 20011.04B-13.24%25.86%1.48B-441.80M0.96
FY200031 Dec 20001.20B+55.22%34.71%1.63B-437.70M1.10
FY199931 Dec 1999771.10M+21.68%24.07%1.08B-304.20M0.72
FY199831 Dec 1998633.70M+23.02%23.98%1.04B-407.80M0.60
FY199731 Dec 1997515.10M-7.31%21.96%902.90M-387.80M0.47
FY199631 Dec 1996555.70M-8.98%25.28%822.60M-266.90M0.49
FY199531 Dec 1995610.50M+52.21%32.07%773.20M-162.70M0.53
FY199431 Dec 1994401.10M+79.78%24.76%531.90M-130.80M0.36
FY199331 Dec 1993223.10M+205.62%16.47%433.00M-209.90M0.20
FY199231 Dec 199273.00M-28.71%6.76%292.80M-219.80M0.06
FY199131 Dec 1991102.40M—15.06%219.70M-117.30M0.09
FY199031 Dec 1990-51.40M—-27.00%13.50M-64.90M-0.08
FY198931 Dec 1989-25.40M——18.70M-44.10M—
FY198831 Dec 1988-49.10M—-69.94%-5.90M-43.20M-0.06

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Amgen's free cash flow

Source: Financial Modeling PrepVerified against SEC filings